Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Trading Plan

Director Gerhard Prante of Cibus Inc. sold 1,150 shares of Class A Common Stock at $2.34 per share on January 13, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Gerhard Prante, a director at Cibus Inc., sold 1,150 shares of Class A Common Stock.
• The sale occurred on January 13, 2025, at a price of $2.34 per share.
• The transaction was executed automatically under a pre-existing Rule 10b5-1 trading plan.
• Following the sale, Prante directly owns 43,357 shares of Cibus Inc. stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale by a director under a pre-arranged plan, which is neither positive nor negative for the company's prospects.

Industry Context

This is a routine disclosure of a stock sale by a company director, which is common in publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among corporate insiders to manage their stock sales and avoid potential insider trading issues.
• The sale of 1,150 shares is a relatively small transaction compared to the total outstanding shares of the company and is unlikely to have a significant impact on the stock price.
• Similar filings are regularly made by directors and officers of publicly traded companies, such as those in the biotechnology sector like Cibus, including companies like Bayer, Corteva, and Syngenta.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Cibus Inc., Gerhard Prante, stock sale, Form 4, Rule 10b5-1, insider trading, director, Class A Common Stock